Themis Medicare Limited — Others, 01-08-2025: Change in Director(s)

Themis Medicare has announced its financial results for the quarter, reporting a standalone net loss of ₹15.37 Cr and consolidated net loss of ₹14.22 Cr. The company's Board has decided to withdraw the previously approved merger with Gujarat Themis Biosyn Limited, focusing instead on its core domestic formulations business for sustainable growth. New appointments include Ms. Neha Thakore as an Additional Independent Director and Mr. Viraj Save as Executive President – Sales & Marketing. The record date for the FY25 final dividend is September 5, 2025. An exceptional item of ₹1.29 Cr was recorded due to a dissolved UK subsidiary.